AIP vs RARE · rev $47.1M vs rev $350.0M
Arteris Inc (AIP) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Arteris Inc (AIP) is a semiconductors company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported AIP revenue for 2026-06-30 was $47.1M. Net income was -$22.0M. AIP currently screens at market cap $387.0M.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
AIP currently screens at market cap $387.0M. RARE currently screens at market cap $2.79B.
Not investment advice. Open the AIP and RARE stock pages for the full models.
Not investment advice.